REGULATED PRESS RELEASE published on 03/29/2024 at 17:45, 1 year 8 months ago NFL BIOSCIENCES: 2023 FULL-YEAR BUSINESS AND EARNINGS UPDATE
BRIEF published on 03/11/2024 at 09:00, 1 year 8 months ago NFL BIOSCIENCES: INITIATION OF ANALYST COVERAGE BY PORTZAMPARC - BNP PARIBAS GROUP NFL Biosciences PORTZAMPARC BNP Paribas Biopharmaceutical Industry Analyst Coverage
BRIEF published on 03/11/2024 at 09:00, 1 year 8 months ago NFL BIOSCIENCES : INITIATION DE COUVERTURE ANALYSTE PAR PORTZAMPARC – GROUPE BNP PARIBAS Marché Financier NFL Biosciences PORTZAMPARC BNP Paribas Couverture Analyste
REGULATED PRESS RELEASE published on 03/11/2024 at 08:55, 1 year 8 months ago NFL BIOSCIENCES: INITIATION OF ANALYST COVERAGE BY PORTZAMPARC - BNP PARIBAS GROUP
REGULATED PRESS RELEASE published on 03/11/2024 at 08:55, 1 year 8 months ago NFL BIOSCIENCES : INITIATION DE COUVERTURE ANALYSTE PAR PORTZAMPARC – GROUPE BNP PARIBAS
ARTICLE published on 02/13/2024 at 18:45, 1 year 9 months ago NFL BIOSCIENCES ANNONCE SA PARTICIPATION AU CONGRÈS DE LA SRNT Présentation des résultats prometteurs de l'étude PRECESTO dans la lutte contre le tabagisme NFL Biosciences Innovation NFL-101 Tabagisme SRNT
REGULATED PRESS RELEASE published on 02/13/2024 at 17:45, 1 year 9 months ago NFL BIOSCIENCES WILL PRESENT THE RESULTS OF THE PRECESTO CLINICAL STUDY AT THE SRNT CONFERENCE, THE WORLD'S LEADING SCIENTIFIC SOCIETY IN THE FIELD OF NICOTINE AND TOBACCO RESEARCH NFL Biosciences to present promising results of the PRECESTO clinical study at the SRNT Conference, focusing on smoking cessation with botanical drug NFL-101. Phase 2b trial ongoing for CESTO 2 NFL Biosciences Smoking Cessation NFL-101 PRECESTO Study CESTO 2
REGULATED PRESS RELEASE published on 02/13/2024 at 17:45, 1 year 9 months ago NFL BIOSCIENCES PRÉSENTERA LES RÉSULTATS DE L’ÉTUDE PRECESTO LORS DU CONGRÈS DE LA SRNT, LA SOCIÉTÉ SCIENTIFIQUE DE RÉFÉRENCE AU NIVEAU MONDIAL DANS LA LUTTE CONTRE LE TABAGISME NFL Biosciences présentera les résultats de l'étude PRECESTO lors du congrès de la SRNT à Édimbourg le 20-23 mars 2024, montrant l'efficacité de NFL-101 dans la réduction de la satisfaction de fumer NFL Biosciences NFL-101 Étude PRECESTO Tabagisme SRNT
REGULATED PRESS RELEASE published on 01/30/2024 at 08:00, 1 year 10 months ago NFL BIOSCIENCES: SUCCESS OF THE STUDY WITH THE CEA NFL BIOSCIENCES announces the successful study with the CEA demonstrating a new mechanism of action for smoking cessation using NFL-101, a botanical drug. Results open new possibilities for addiction treatment NFL Biosciences Addiction Treatment CEA Study Smoking Cessation NFL-101
REGULATED PRESS RELEASE published on 01/30/2024 at 08:00, 1 year 10 months ago NFL BIOSCIENCES : SUCCÈS DE L’ÉTUDE AVEC LE CEA NFL BIOSCIENCES annonce la mise en ubrique, étude d'imagerie moléculaire menée par le CEA, du mécanisme d'action innovant du candidat médicament NFL-101 pour le sevrage tabagique NFL Biosciences Étude D'imagerie Moléculaire Sevrage Tabagique CEA Mécanisme D'action
Published on 12/05/2025 at 02:35, 7 hours 59 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 9 hours 34 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 29 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 34 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 10:15, 19 minutes ago Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 54 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 1 hour 4 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 29 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 1 hour 33 minutes ago Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 08:45, 1 hour 49 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 1 hour 49 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 1 hour 52 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 16 hours 19 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 16 hours 34 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025